Please check your internet connection and try again.
# Lorazepam
## Overview
Lorazepam is a short-acting benzodiazepine with anxiolytic, sedative, hypnotic, anticonvulsant, and muscle relaxant properties.
## Primary Indications
* Anxiety disorders
* Insomnia
* Seizure disorders (e.g., status epilepticus)
* Premedication for surgical procedures
* Management of agitation
## Adult Dosing
* **Anxiety:** 0.5 mg to 2 mg orally every 6 to 8 hours as needed. Doses may be increased based on response, up to a maximum of 10 mg per day.
* **Insomnia:** 2 mg to 4 mg orally at bedtime.
* **Status Epilepticus:** 4 mg intravenously or intramuscularly. A second dose of 4 mg may be given 5 to 10 minutes after the first if seizures persist. Maximum initial dose is 8 mg.
* **Premedication:** 1 mg to 4 mg orally or intramuscularly 2 hours before surgery, or 2 mg to 4 mg intravenously 15 to 30 minutes before surgery.
## Pediatric Dosing
Dosing in children is less well established and should be individualized based on weight, age, and clinical condition. A common guideline for status epilepticus is 0.05 mg/kg to 0.1 mg/kg intravenously, not to exceed 4 mg per dose. Lower doses are generally recommended for anxiety or sedation.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution, may require dose reduction.
* **Renal Impairment:** Use with caution; no specific dose adjustment is usually recommended, but monitor for increased effects.
* **Elderly:** Start with lower doses (e.g., 0.5 mg to 1 mg orally twice daily) and titrate slowly due to increased sensitivity and risk of adverse effects.
## Contraindications
* Hypersensitivity to lorazepam or other benzodiazepines
* Acute narrow-angle glaucoma
* Severe respiratory insufficiency
* Severe hepatic insufficiency
* Sleep apnea
## Adverse Effects
Common: Drowsiness, dizziness, weakness, unsteadiness, confusion.
Serious: Respiratory depression, paradoxical excitation, anterograde amnesia, dependence, withdrawal symptoms.
## Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, other sedatives):** Potentiates CNS depression, leading to increased sedation, respiratory depression, and potentially fatal outcomes. Exercise extreme caution and consider dose reduction of one or both agents.
* **Valproic Acid:** May increase lorazepam levels and prolong its elimination. Consider dose reduction of lorazepam.
* **Theophylline/Aminophylline:** May reduce the sedative effects of lorazepam.
## Monitoring
* **Mental status:** Assess for sedation, confusion, and paradoxical reactions.
* **Respiratory status:** Monitor respiratory rate and depth, especially with IV administration or concurrent CNS depressants.
* **Vital signs:** Particularly important with IV administration.
* **Signs of withdrawal:** If discontinuing after prolonged use.
* **Effectiveness:** Assess for improvement in anxiety, insomnia, or seizure control.
## Clinical Pearls
* Intravenous lorazepam is the drug of choice for status epilepticus due to its rapid onset and relatively favorable safety profile compared to diazepam.
* IM administration may be less predictable than IV or oral routes due to potential variations in absorption.
* Avoid abrupt discontinuation after prolonged use; taper gradually to prevent withdrawal symptoms.
* Lorazepam is often preferred in patients with hepatic dysfunction compared to other benzodiazepines due to its metabolism.
* Pregnancy Category D. Use only if potential benefit justifies the potential risk to the fetus.
***
**Disclaimer:** This information is intended for clinical use and is not a substitute for professional medical judgment. Always consult the most current prescribing information and relevant clinical guidelines before making treatment decisions. Dosing may vary based on patient-specific factors and local institutional protocols.
